1a,25-Dihydroxy-2b-(30-hydroxypropoxy)-19-norprevitamin D3

ID: ALA465286

Chembl Id: CHEMBL465286

PubChem CID: 44570200

Max Phase: Preclinical

Molecular Formula: C29H48O5

Molecular Weight: 476.70

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/C=C\C3=C[C@@H](O)[C@H](OCCCO)[C@H](O)C3)=CCC[C@]12C

Standard InChI:  InChI=1S/C29H48O5/c1-20(8-5-14-28(2,3)33)23-12-13-24-22(9-6-15-29(23,24)4)11-10-21-18-25(31)27(26(32)19-21)34-17-7-16-30/h9-11,18,20,23-27,30-33H,5-8,12-17,19H2,1-4H3/b11-10-/t20-,23-,24+,25-,26-,27+,29-/m1/s1

Standard InChI Key:  IJKZNHLEQHEHRO-VPWGJZQSSA-N

Associated Targets(Human)

GC Tchem Vitamin D-binding protein (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

VDR Vitamin D3 receptor (135 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.70Molecular Weight (Monoisotopic): 476.3502AlogP: 4.69#Rotatable Bonds: 11
Polar Surface Area: 90.15Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.54CX Basic pKa: CX LogP: 3.37CX LogD: 3.37
Aromatic Rings: Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: 2.36

References

1. Sánchez-Abella L, Fernández S, Verstuyf A, Verlinden L, Gotor V, Ferrero M..  (2008)  Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.,  16  (24): [PMID:19006670] [10.1016/j.bmc.2008.10.053]

Source